Increased MAL2 levels in breast cancer cell lines favored the formation of signaling complexes with the transmembrane tyrosine kinase receptor HER2 in membrane protrusions (Figure 6D), contributing to the persistence of activated HER2 on the plasma membrane [147]. Here, ERBB2 is linked to breast carcinoma.